Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group

Charles E. Canter, Robert E. Shaddy, Daniel Bernstein, Daphne T. Hsu, Maryanne R K Chrisant, James K. Kirklin, Kirk R. Kanter, Robert S D Higgins, Elizabeth D. Blume, David N. Rosenthal, Mark M. Boucek, Karen C. Uzark, Allen H. Friedman, James K. Young

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

BACKGROUND - Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure. METHODS AND RESULTS - A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed. CONCLUSIONS - This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.

Original languageEnglish (US)
Pages (from-to)658-676
Number of pages19
JournalCirculation
Volume115
Issue number5
DOIs
StatePublished - Feb 2007
Externally publishedYes

Fingerprint

Cardiovascular Nursing
Quality of Health Care
Heart Transplantation
Cardiology
Heart Diseases
Cardiovascular Diseases
Anesthesia
Outcome Assessment (Health Care)
Pediatrics
Cardiomyopathies
Heart Failure
Therapeutics
Guidelines

Keywords

  • AHA Scientific Statements
  • Pediatrics
  • Transplantation

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Indications for heart transplantation in pediatric heart disease : A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. / Canter, Charles E.; Shaddy, Robert E.; Bernstein, Daniel; Hsu, Daphne T.; Chrisant, Maryanne R K; Kirklin, James K.; Kanter, Kirk R.; Higgins, Robert S D; Blume, Elizabeth D.; Rosenthal, David N.; Boucek, Mark M.; Uzark, Karen C.; Friedman, Allen H.; Young, James K.

In: Circulation, Vol. 115, No. 5, 02.2007, p. 658-676.

Research output: Contribution to journalArticle

Canter, Charles E. ; Shaddy, Robert E. ; Bernstein, Daniel ; Hsu, Daphne T. ; Chrisant, Maryanne R K ; Kirklin, James K. ; Kanter, Kirk R. ; Higgins, Robert S D ; Blume, Elizabeth D. ; Rosenthal, David N. ; Boucek, Mark M. ; Uzark, Karen C. ; Friedman, Allen H. ; Young, James K. / Indications for heart transplantation in pediatric heart disease : A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. In: Circulation. 2007 ; Vol. 115, No. 5. pp. 658-676.
@article{57a1b3c272044feba870082de51243f3,
title = "Indications for heart transplantation in pediatric heart disease: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group",
abstract = "BACKGROUND - Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure. METHODS AND RESULTS - A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed. CONCLUSIONS - This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.",
keywords = "AHA Scientific Statements, Pediatrics, Transplantation",
author = "Canter, {Charles E.} and Shaddy, {Robert E.} and Daniel Bernstein and Hsu, {Daphne T.} and Chrisant, {Maryanne R K} and Kirklin, {James K.} and Kanter, {Kirk R.} and Higgins, {Robert S D} and Blume, {Elizabeth D.} and Rosenthal, {David N.} and Boucek, {Mark M.} and Uzark, {Karen C.} and Friedman, {Allen H.} and Young, {James K.}",
year = "2007",
month = "2",
doi = "10.1161/CIRCULATIONAHA.106.180449",
language = "English (US)",
volume = "115",
pages = "658--676",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - Indications for heart transplantation in pediatric heart disease

T2 - A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group

AU - Canter, Charles E.

AU - Shaddy, Robert E.

AU - Bernstein, Daniel

AU - Hsu, Daphne T.

AU - Chrisant, Maryanne R K

AU - Kirklin, James K.

AU - Kanter, Kirk R.

AU - Higgins, Robert S D

AU - Blume, Elizabeth D.

AU - Rosenthal, David N.

AU - Boucek, Mark M.

AU - Uzark, Karen C.

AU - Friedman, Allen H.

AU - Young, James K.

PY - 2007/2

Y1 - 2007/2

N2 - BACKGROUND - Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure. METHODS AND RESULTS - A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed. CONCLUSIONS - This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.

AB - BACKGROUND - Since the initial utilization of heart transplantation as therapy for end-stage pediatric heart disease, improvements have occurred in outcomes with heart transplantation and surgical therapies for congenital heart disease along with the application of medical therapies to pediatric heart failure that have improved outcomes in adults. These events justify a reevaluation of the indications for heart transplantation in congenital heart disease and other causes of pediatric heart failure. METHODS AND RESULTS - A working group was commissioned to review accumulated experience with pediatric heart transplantation and its use in patients with unrepaired and/or previously repaired or palliated congenital heart disease (children and adults), in patients with pediatric cardiomyopathies, and in pediatric patients with prior heart transplantation. Evidence-based guidelines for the indications for heart transplantation or retransplantation for these conditions were developed. CONCLUSIONS - This evaluation has led to the development and refinement of indications for heart transplantation for patients with congenital heart disease and pediatric cardiomyopathies in addition to indications for pediatric heart retransplantation.

KW - AHA Scientific Statements

KW - Pediatrics

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=33846927773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846927773&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.106.180449

DO - 10.1161/CIRCULATIONAHA.106.180449

M3 - Article

C2 - 17261651

AN - SCOPUS:33846927773

VL - 115

SP - 658

EP - 676

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 5

ER -